Home > Publications Database > Dementia risk reduction in the African context: Multi-national implementation of multimodal strategies to promote healthy brain aging in Africa (the Africa-FINGERS project). > print

001     274035
005     20250119000237.0
024 7 _ |a 10.1002/alz.14344
|2 doi
024 7 _ |a pmid:39511921
|2 pmid
024 7 _ |a pmc:PMC11667543
|2 pmc
024 7 _ |a 1552-5260
|2 ISSN
024 7 _ |a 1552-5279
|2 ISSN
024 7 _ |a altmetric:170191296
|2 altmetric
037 _ _ |a DZNE-2025-00016
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Udeh-Momoh, Chinedu T
|b 0
245 _ _ |a Dementia risk reduction in the African context: Multi-national implementation of multimodal strategies to promote healthy brain aging in Africa (the Africa-FINGERS project).
260 _ _ |a Hoboken, NJ
|c 2024
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1736337931_19585
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Dementia prevention in Africa is critically underexplored, despite the continent's high prevalence of modifiable risk factors. With a predominantly young and middle-aged population, Africa presents a prime opportunity to implement evidence-based strategies that could significantly reduce future dementia cases and mitigate its economic impact. The multinational Africa-FINGERS program offers an innovative solution, pioneering culturally sensitive, multidomain interventions tailored to the unique challenges of the region. Leveraging insights from landmark global studies such as Worldwide-FINGERS and Alzheimer's Disease Neuroimaging Initiative, the program employs a multideterminant precision prevention framework, grounded in community based systems dynamics. Africa-FINGERS further integrates cutting-edge state-of-the-art multimodal biomarker evaluations tailored to regional contexts, with the goal of advancing brain health and establishing a global standard for dementia prevention. This groundbreaking initiative highlights the potential for scalableand sustainable interventions, thus is poised to transform dementia risk reduction efforts across the continent. HIGHLIGHTS: Dementia rates are escalating in Africa, largely due to longer life spans and increased prevalence of modifiable risk factors. Yet, few regional interventions have directly targeted lifestyle factors to reduce dementia risk. The multinational Africa-FINGERS study will address this gap by adapting the successful FINGERS lifestyle intervention to African populations. Africa-FINGERS will pioneer a culturally informed, multidomain dementia risk reduction intervention in the African region through feasibility dementia prevention trials in rural and urban sites across Kenya and Nigeria in the first instance, enrolling 600 at-risk adults (≥ 50 years). The program adopts participatory research methods to develop culturally appropriate interventions and build infrastructure to evaluate dementia biomarkers from ante and post mortem samples. A cost-effectiveness analysis will be conducted to guide the strategic implementation of Africa-FINGERS into regional health systems. The Africa-FINGERS strategy aligns with the Worldwide-FINGERS framework and integrates the global Alzheimer's Disease Neuroimaging Initiative approach, emphasizing multimodal analysis.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Alzheimer's disease
|2 Other
650 _ 7 |a brain banking
|2 Other
650 _ 7 |a community‐based participatory research
|2 Other
650 _ 7 |a dementia prevention trials
|2 Other
650 _ 7 |a fluid and neuroimaging biomarkers
|2 Other
650 _ 7 |a health economics
|2 Other
650 _ 7 |a implementation science
|2 Other
650 _ 7 |a retinal imaging
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Risk Reduction Behavior
|2 MeSH
650 _ 2 |a Africa: epidemiology
|2 MeSH
650 _ 2 |a Dementia: prevention & control
|2 MeSH
650 _ 2 |a Dementia: epidemiology
|2 MeSH
650 _ 2 |a Brain
|2 MeSH
650 _ 2 |a Risk Factors
|2 MeSH
650 _ 2 |a Healthy Aging
|2 MeSH
650 _ 2 |a Neuroimaging
|2 MeSH
700 1 _ |a Maina, Rachel
|b 1
700 1 _ |a Anazodo, Udunna C
|b 2
700 1 _ |a Akinyemi, Rufus
|b 3
700 1 _ |a Atwoli, Lukoye
|b 4
700 1 _ |a Baker, Laura
|b 5
700 1 _ |a Bassil, Darina
|b 6
700 1 _ |a Blackmon, Karen
|b 7
700 1 _ |a Bosire, Edna
|b 8
700 1 _ |a Chemutai, Gloria
|b 9
700 1 _ |a Crivelli, Lucia
|b 10
700 1 _ |a Eze, Laz U
|b 11
700 1 _ |a Ibanez, Agustin
|b 12
700 1 _ |a Kafetsouli, Dimitra
|b 13
700 1 _ |a Karikari, Thomas K
|b 14
700 1 _ |a Khakali, Linda
|b 15
700 1 _ |a Kumar, Manasi
|b 16
700 1 _ |a Lengyel, Imre
|b 17
700 1 _ |a de Jager Loots, Celeste A
|b 18
700 1 _ |a Mangialasche, Francesca
|b 19
700 1 _ |a Mbugua, Sylvia
|b 20
700 1 _ |a Merali, Zul
|b 21
700 1 _ |a Mielke, Michelle
|b 22
700 1 _ |a Mostert, Cyprian
|b 23
700 1 _ |a Muthoni, Eunice
|b 24
700 1 _ |a Nesic-Taylor, Olivera
|b 25
700 1 _ |a Ngugi, Anthony
|b 26
700 1 _ |a Nguku, Samuel
|b 27
700 1 _ |a Ogunniyi, Adesola
|b 28
700 1 _ |a Ogunyemi, Adedoyin
|b 29
700 1 _ |a Okonkwo, Ozioma C
|b 30
700 1 _ |a Okubadejo, Njideka
|b 31
700 1 _ |a Perneczky, Robert
|0 P:(DE-2719)2812234
|b 32
|u dzne
700 1 _ |a Peto, Tunde
|b 33
700 1 _ |a Riang'a, Roselyter M
|b 34
700 1 _ |a Saleh, Mansoor
|b 35
700 1 _ |a Sayed, Shaheen
|b 36
700 1 _ |a Shah, Jasmit
|b 37
700 1 _ |a Shah, Sheena
|b 38
700 1 _ |a Solomon, Alina
|b 39
700 1 _ |a Thesen, Thomas
|b 40
700 1 _ |a Trepel, Dominic
|b 41
700 1 _ |a Ucheagwu, Valentine
|b 42
700 1 _ |a Valcour, Victor
|b 43
700 1 _ |a Waa, Sheila
|b 44
700 1 _ |a Watermeyer, Tamlyn
|b 45
700 1 _ |a Yokoyama, Jennifer
|b 46
700 1 _ |a Zetterberg, Henrik
|b 47
700 1 _ |a Kivipelto, Miia
|b 48
700 1 _ |a Team, Africa-FINGERS Study
|b 49
|e Collaboration Author
773 _ _ |a 10.1002/alz.14344
|g Vol. 20, no. 12, p. 8987 - 9003
|0 PERI:(DE-600)2201940-6
|n 12
|p 8987 - 9003
|t Alzheimer's and dementia
|v 20
|y 2024
|x 1552-5260
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/274035/files/DZNE-2025-00016.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/274035/files/DZNE-2025-00016.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:274035
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 32
|6 P:(DE-2719)2812234
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-25
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2023-10-25
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2023-10-25
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-25
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-25
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-25
920 1 _ |0 I:(DE-2719)5000022
|k AG Dichgans
|l Vascular Cognitive Impairment & Post-Stroke Dementia
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)5000022
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21